Demand for prescription medications in the U.S. is at an all time high, given that 50% of adults have at least one chronic condition, and 25% have two or more. Sixty percent of the population, and 90% of Medicare beneficiaries ...
Sep 11, 2019
0
2
(HealthDay)—The economic burden of disease progression is considerable among multiple myeloma (MM) patients receiving drug therapy across all lines of therapy (LOTs), according to a study published online Aug. 7 in Leukemia ...
Aug 15, 2019
0
4
New research, published in the Milbank Quarterly, highlights the potential health and economic impact of the United States (US) Food and Drug Administration's (FDA) proposed voluntary salt policy on workers in the US food ...
Jul 24, 2019
0
1
Lawmakers are trying to set aside their irreconcilable differences over the Obama-era Affordable Care Act and work to reach bipartisan agreement on a more immediate health care issue, lowering costs for people who already ...
Jul 7, 2019
1
0
Efforts to control health care costs in the United States often focus on the listed prescription drug prices, but a perspective published by the Journal of the American Medical Association suggests that unregulated pharmacy ...
Jun 21, 2019
0
1
The introduction of infliximab (Remicade), the first biologic therapy approved for the treatment of inflammatory bowel diseases (IBD), did not result in lower rates of hospitalizations or intestinal surgeries among patients ...
Jun 13, 2019
0
2
As direct-to-consumer marketing becomes pervasive, there's a growing trend of Do-It-Yourself or DIY dentistry—prompting patients to skip the trip to the orthodontist in favor of at-home impression kits and the ability to ...
May 29, 2019
1
0
(HealthDay)—A solid minority of senior citizens still struggles to afford their prescription medications, a new government report shows.
May 22, 2019
0
1
TV pitches for prescription drugs will soon include the price, giving consumers more information upfront as they make medication choices at a time when new drugs can carry anxiety-inducing prices.
May 8, 2019
0
1
The amount of money people pay out-of-pocket for drugs to treat neurologic conditions like multiple sclerosis, dementia and Parkinson's disease has risen sharply over 12 years, with the most dramatic increase for multiple ...
May 1, 2019
0
1
